Skip to Main Content
An official website of the United States government
Login Change: CDAS is now using the NIH Researcher Auth Service (RAS) to manage our existing login options. When logging into CDAS, you will be taken to RAS, where you can select your preferred login provider to access CDAS.

Approved Projects

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Filter results of approved projects table below

Showing Most Recent
21-40 of 2736
Approved Projects
Name Principal Investigator Institution Study Date Approved Project ID
AEGIS-Lung — Deep-Learning Development and Internal Validation of an Integrated Lung-Cancer Risk Model in the NLST Cohort Aneel Paulus West Eastern Health NLST Jul 14, 2026 NLST-1522
NeuroAI-Lung: Longitudinal Risk Stratification Using NLST Low-Dose CT Data Richard Tran Trove-AI NLST Jul 14, 2026 NLST-1519
PLCO Germline Materials for Integrated Whole-Genome Discovery of Lung Cancer Susceptibility with the Sherlock-Lung Study Maria Teresa Landi National Cancer Institute, National Institutes of Health PLCO Jul 8, 2026 2026-0117
Repurposing: Efficient use of excess PLCO biospecimens to investigate DNA methylation patterns and cardiovascular disease mortality risk Jason Wong National Heart Lung and Blood Institute PLCO Jun 25, 2026 2026-8083
ABO Blood Type and Secretor Status as Determinants of Oral Microbiome Composition and Cancer Risk: Evidence from the PLCO Cohort Emily Vogtmann National Cancer Institute PLCO Jun 18, 2026 PLCO-2058
Longitudinal study of socioeconomic factors, stress-related biomarkers, and aggressive prostate cancer Kathryn Barry University of Maryland, Baltimore PLCO Jun 17, 2026 2026-0158
Multi-population study of serum protein biomarkers and prostate cancer risk Sonja Berndt National Cancer Institute PLCO Jun 17, 2026 2026-0154
Leveraging antibody responses against transposable elements as a novel immune therapy for ovarian cancer Rebecca Lynch The George Washington University School of Medicine and Health Sciences PLCO Jun 17, 2026 2026-0096
Exosome-based microRNA Biomarkers for Non-invasive and Early Detection of Colorectal Cancer and Advanced Adenomas Ajay Goel City of Hope PLCO Jun 16, 2026 2025-0016
Efficient Design and Analysis of Two-Phase Biomarker Studies Li Cheung National Cancer Institute PLCO Jun 8, 2026 PLCO-2053
PLCO Digital Pathology Whole-Slide Images for Prostate, Lung, and Ovarian Cancer AI Modeling and Validation Yuming Jiang Wake Forest University Health Sciences PLCO Jun 8, 2026 PLCOI-2052
Impact of deep learning lung cancer risk models on clinical decisions with blood-based diagnostics Michael Kammer Biodesix, inc NLST Jun 8, 2026 NLST-1515
Designing a Targeted Lung Cancer (LC) Screening Trial in the U.S. Screening-Ineligible Population Using Synthetic Cohorts and Natural History Modelling Thomas Trikalinos Brown University PLCO Jun 1, 2026 PLCO-2047
Scalable and Reproducible Deep Learning Strategies for Lung Cancer Screening Imaging Stefano Diciotti Alma Mater Studiorum - Department DEI NLST Jun 1, 2026 NLST-1514
Deep Learning to Improve Screening of Interstitial Lung Diseases (NLST-1505 continued) Charles Hatt IMBIO, a 4D Medical Company NLST Jun 1, 2026 NLST-1506
Heterogeneity of screening effects (Original Project: NLST-1098) Hormuzd Katki American Cancer Society NLST May 29, 2026 NLST-1509
Behavioral effects of screening offers Ethan Lieber University of Notre Dame du Lac PLCO May 29, 2026 PLCO-2044
Estimating the intake of moderation foods and evaluating associations with metabolomic and microbiome measures Kaelyn Burns National Cancer Institute IDATA May 11, 2026 IDATA-99
Studies to use extended NLST follow-up data (Original Project: NLST-626) Hormuzd Katki American Cancer Society NLST May 11, 2026 NLST-1508
Validation of the Michigan General Cancer Screening Model (M-GCSM) Using the National Lung Screening Trial Dataset Tanner Caverly Department of Veterans Affairs NLST May 11, 2026 NLST-1513